Executive Team

President and Chief Executive Officer

Anita M Holcslaw, RPh

After graduating with high honors from Purdue University School of Pharmacy and Pharmacal Sciences, Anita spent the next 25 years in independent retail and hospital pharmacy practice followed by 5 years in clinical drug development at SmithKline Beecham as a clinical scientist involved in managing clinical drug trials. She later received extensive clinical writing experience in a Medical Communications Company. She formed New Drug Development Services, Inc in the fall of 2004.

Vice President of New Business Development and Consulting Services

Terry L Holcslaw, MS, PhD

Dr. Holcslaw graduated from the University of Arizona with a BS degree in Chemistry and Biology. He later received a MS and PhD degree in Pharmacology and Toxicology from Purdue University. After 13 years on the faculty of the School of Pharmacy and School of Medicine at the University of Nebraska, Dr. Holcslaw joined SmithKline French Pharmaceuticals in 1986 as a senior clinical scientist in the clinical drug development division. He assumed appointments of increasing importance over the next 10 years becoming Senior Director of Clinical Drug Development in 1996. He left this position in the newly formed GlaxoSmithKline in July 2005 to become Vice President of New Business Development and Consulting in New Drug Development Services, Inc. He has over 35 years of drug discovery, drug development and clinical writing experience. This experience has included authorship of peer reviewed publications and as well as preparation of a variety of clinical drug development regulatory and non-regulatory writing endeavors.